BerandaTWST • NASDAQ
add
Twist Bioscience Corp
$36,94
Setelah Jam Perdagangan Normal:(0,00%)0,00
$36,94
Tutup: 26 Jun, 16.10.10 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$36,99
Rentang hari
$36,08 - $37,48
Rentang tahun
$27,12 - $60,90
Kapitalisasi pasar
2,21Â M USD
Volume Rata-Rata
1,17Â jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(USD) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Pendapatan | 92,79Â jt | 23,23% |
Biaya operasional | 87,59Â jt | 9,80% |
Laba bersih | -39,33Â jt | 13,55% |
Margin laba bersih | -42,38 | 29,85% |
Penghasilan per saham | -0,66 | 16,46% |
EBITDA | -35,16Â jt | 13,38% |
Tarif pajak efektif | -0,45% | — |
Neraca
Total aset
Total liabilitas
(USD) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 257,15Â jt | -12,34% |
Total aset | 595,62Â jt | -15,26% |
Total liabilitas | 155,51Â jt | 8,96% |
Total ekuitas | 440,11 jt | — |
Saham yang beredar | 59,92 jt | — |
Harga terhadap nilai buku | 5,03 | — |
Tingkat pengembalian aset | -17,26% | — |
Tingkat pengembalian modal | -19,62% | — |
Arus Kas
Perubahan kas bersih
(USD) | Mar 2025info | Perubahan Y/Y |
---|---|---|
Laba bersih | -39,33Â jt | 13,55% |
Kas dari operasi | -12,99Â jt | 33,14% |
Kas dari investasi | -1,43Â jt | 72,79% |
Kas dari pembiayaan | 3,20Â jt | 74,84% |
Perubahan kas bersih | -11,11Â jt | 51,48% |
Arus kas bebas | -5,15Â jt | 14,52% |
Tentang
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Didirikan
2013
Situs
Karyawan
923